Guangdong Hybribio Biotech Co.,Ltd.

SZSE:300639 Stock Report

Market Cap: CN¥4.4b

Guangdong Hybribio BiotechLtd Future Growth

Future criteria checks 3/6

Guangdong Hybribio BiotechLtd is forecast to grow earnings at 78.4% per annum. EPS is expected to grow by 80.6% per annum.

Key information

78.4%

Earnings growth rate

80.6%

EPS growth rate

Biotechs earnings growth43.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updated03 Jun 2024

Recent future growth updates

No updates

Recent updates

Guangdong Hybribio Biotech Co.,Ltd.'s (SZSE:300639) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Oct 08
Guangdong Hybribio Biotech Co.,Ltd.'s (SZSE:300639) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Is Guangdong Hybribio BiotechLtd (SZSE:300639) Using Debt In A Risky Way?

Sep 29
Is Guangdong Hybribio BiotechLtd (SZSE:300639) Using Debt In A Risky Way?

Guangdong Hybribio Biotech Co.,Ltd.'s (SZSE:300639) 77% Share Price Surge Not Quite Adding Up

Aug 19
Guangdong Hybribio Biotech Co.,Ltd.'s (SZSE:300639) 77% Share Price Surge Not Quite Adding Up

Guangdong Hybribio BiotechLtd (SZSE:300639) Is Reducing Its Dividend To CN¥0.065

May 22
Guangdong Hybribio BiotechLtd (SZSE:300639) Is Reducing Its Dividend To CN¥0.065

There May Be Some Bright Spots In Guangdong Hybribio BiotechLtd's (SZSE:300639) Earnings

May 03
There May Be Some Bright Spots In Guangdong Hybribio BiotechLtd's (SZSE:300639) Earnings

Earnings and Revenue Growth Forecasts

SZSE:300639 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024864-294-16174N/A
6/30/2024907-59-22214N/A
3/31/202498561-92186N/A
12/31/20231,104140-66320N/A
9/30/20232,189410195792N/A
6/30/20233,3618713131,012N/A
3/31/20234,3881,2925431,259N/A
1/1/20235,5971,7265751,309N/A
9/30/20224,9401,6933601,080N/A
6/30/20224,2171,439294994N/A
3/31/20223,5741,18091801N/A
1/1/20222,673852-10631N/A
9/30/20212,429736-110449N/A
6/30/20212,148625-181276N/A
3/31/20211,814515-78286N/A
12/31/20201,35436324311N/A
9/30/20201,12931619184N/A
6/30/2020918216-75135N/A
3/31/2020742150-10689N/A
12/31/2019729147-84113N/A
9/30/2019693141-86104N/A
6/30/2019648128-5889N/A
3/31/2019610119-6290N/A
12/31/2018580114-6480N/A
9/30/2018548107-6568N/A
6/30/2018518102N/A73N/A
3/31/201849996N/A72N/A
12/31/201747993N/A79N/A
9/30/201745589N/A79N/A
6/30/201743180N/A59N/A
3/31/201741177N/A67N/A
12/31/201639876N/A64N/A
12/31/201534565N/A48N/A
12/31/201426463N/A35N/A
12/31/201318329N/A23N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300639 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).

Earnings vs Market: 300639 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 300639 is expected to become profitable in the next 3 years.

Revenue vs Market: Insufficient data to determine if 300639's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 300639's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 300639's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y